{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-257651","form_type":"8-K","ticker":"NUVL","cik":"0001861560","company_name":"Nuvalent, Inc.","filed_at":"2023-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.166481+00:00","generated_at":"2026-06-09T22:49:14.427894+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nuvalent prices $300M public offering of 5.36M shares at $56.00/share","bullets":["Sold 5,357,143 shares at $56.00 each; gross proceeds ~$300M.","Net proceeds est. ~$281.6M (or ~$323.9M if underwriters exercise option for 803,571 additional shares).","Underwriters: J.P. Morgan, TD Cowen, Piper Sandler, BMO Capital Markets; close expected Oct 19, 2023.","Company expects net proceeds + existing cash to fund operations into 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-257651","json":"https://secwatch.observer/filing/0001193125-23-257651.json","markdown":"https://secwatch.observer/filing/0001193125-23-257651.md","text":"https://secwatch.observer/filing/0001193125-23-257651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861560/000119312523257651/0001193125-23-257651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861560/000119312523257651/d544267d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T22:49:14.427894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b5339f02171f458397db2395a472530a6d0b59cc","claim":"Nuvalent, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Sandler & Co. and BMO Capital Markets Corp., as representatives of the several underwriters (effective 2023-10-16).","evidence_excerpt":"On October 16, 2023, Nuvalent, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Sandler & Co. and BMO Capital Markets Corp., as representatives of the several underwriters (the “Underwriters”), relating to an underwritten public offering (the “Offering”) of 5,357,143 shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861560/000119312523257651/0001193125-23-257651-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Sandler & Co. and BMO Capital Markets Corp., as representatives of the several underwriters"},{"label":"Effective","value":"2023-10-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}